Catalyst Wire Dossier Catalyst Wire Dossier

VABRINTY

LEUPROLIDE ACETATE · URONOVA PHARMACEUTICALS, INC.
Drug timelines are a Plus or Pro feature.

66 regulatory and trial events tracked for VABRINTY, covering 2006-09-29 to 2025-02-24. Get the full timeline:

Most recent: FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)

See pricing